Esophageal adenocarcinoma · 4 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
FLOT Variant #03 | — | R 7 216 | 21d | — | 50.0 mo | — | — | 2 |
ECF Variant #04 | — | R 3 931 | 21d | — | 35.0 mo | — | — | 2 |
ECX Variant #01 | — | R 2 313 | 21d | — | 30.6 mo | — | — | 3 |
Cisplatin and Fluorouracil (CF) Variant #29 | — | R 1 900 | 21d | — | 23.4 mo | — | — | 2 |
4 of 4 regimens shown